Tadafumi Terada

Antitumor agents. 3. Synthesis and biological activity of 4.beta.-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agents

Tadafumi Terada, Katsuhiko Fujimoto, Makoto Nomura et al. · Journal of Medicinal Chemistry · 1993 · 64 citations · Full text

Synthesis of 24,24-difluoro- and 24ξ-fluoro-25-hydroxyvitamin D3

Yoshiro Kobayashi, Takeo Taguchi, Tadafumi Terada et al. · Tetrahedron Letters · 1979 · 42 citations

Medicinal Chemistry, Engineering, 24ξ-Fluoro-25-hydroxyvitamin D3 +3

TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.

Yasuji Yamamoto, Jiro Shibata, Kazuhiko Yonekura et al. · PubMed · 2005 · 34 citations

Gynecology, Pharmacotherapy, E2-dependent Tumor Growth +16

Antitumor Agents. I. DNA Topoisomerase II Inhibitory Activity and the Structural Relationship of Podophyllotoxin Derivatives as Antitumor Agents.

Tadafumi Terada, Katsuhiko Fujimoto, Makoto Nomura et al. · Chemical and Pharmaceutical Bulletin · 1992 · 32 citations · Full text

Pharmacotherapy, Tumor Biology, Medicinal Chemistry +16

Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity

Kenji Suzuki, Hideko Nagasawa, Yoshihiro Uto et al. · Bioorganic & Medicinal Chemistry · 2005 · 32 citations

P300 Gene Expression, Novel Dna, Oncogenic Agent +7